DIRS.INFO The most relevant business & tech news

☆ Goldman Sachs just refreshed its conviction lists of global stocks — giving one 67% upside
▼ + stars: | 2024-05-06 | by ( Amala Balakrishner | In Amala-Balakrishner | ) www.cnbc.com time to read: +3 min

Goldman Sachs just refreshed its lists of top global stock picks, adding some and removing others. The investment bank's "Conviction List - Directors' Cut" aims to offer investors a "curated and active" list of 15 to 25 buy-rated stocks. The stocks are selected by a subcommittee designated by the bank's Investment Review Committee for each region. Here are three of the latest additions to Goldman's directors' cut lists — for Asia-Pacific and Europe — that were given more than 30% upside potential in the next 12 months. Goldman has a target price of 11,850 British pence ($148.71) on the stock, giving it around 30.7% upside potential.

Persons: Goldman Sachs, Goldman, London Stock Exchange Goldman, Oliver Carruthers, Samsung Biologics Goldman, Ziyi Chen, Michele Della Vigna, — CNBC's Michael Bloom Organizations: bank's Investment, London Stock Exchange, Microsoft, Samsung, Korean, EU's Renewable Energy, . Locations: Asia, Pacific, Europe, Korean

Gene therapy has allowed several children born with inherited deafness to hear. Globally, 34 million children have deafness or hearing loss, and genes are responsible for up to 60% of cases. Hereditary deafness is the latest condition scientists are targeting with gene therapy, which is already approved to treat illnesses such as sickle cell disease and severe hemophilia. Also, some people consider gene therapy for deafness ethically problematic. "This is real proof showing gene therapy is working,” Chen said.

Persons: ”, Zheng, Yi Chen, Dr, Yilai Shu, Chen, Eli Lilly, Akouos, he's, John Germiller, ” Germiller, “, Lawrence Lustig, Teresa Blankmeyer Burke, ” Chen Organizations: Children's Hospital of Philadelphia, Fudan University, Shanghai Refreshgene Therapeutics, Regeneron Pharmaceuticals, Decibel Therapeutics, Columbia, Gallaudet University, Associated Press Health, Science Department, Howard Hughes Medical Institute’s Science, Educational Media Group, AP Locations: China, Shanghai, Philadelphia, Spain

☆ Goldman says this biotech could become a global cell therapy leader, has nearly 40% upside
▼ + stars: | 2023-11-06 | by ( Alex Harring | ) www.cnbc.com time to read: +1 min

Legend Biotech has a best-in-class product and could become a global leader in the cell and gene therapy space, according to Goldman Sachs. "We believe Legend has the potential to grow into a leading global cell therapy company," Chen said in a note to clients. Its leading therapy in the space is Carvykti, which he described as "best-in-class." In partnership with Johnson & Johnson , Carvykti is undergoing capacity expansion in the U.S. and European Union to meet demand. Legend stock rose 0.3% in Monday's session.

Persons: Goldman Sachs, Ziyi Chen, Chen, Johnson, Carvykti, — CNBC's Michael Bloom Organizations: Biotech, Johnson, Union Locations: U.S

☆ ‘Twilight Zone: The Movie’ and the Deadly Accident That Plagued It
▼ + stars: | 2023-06-25 | by ( Jason Bailey | ) www.nytimes.com time to read: +2 min

When the anthology film “Twilight Zone: The Movie” opened on June 24, 1983, reviews were mixed; The New York Times’s Vincent Canby deemed it “a flabby, mini-minded behemoth,” and that was a fairly representative view. Chased by a military helicopter, Morrow’s character was to carry two Vietnamese children across a river to safety as a village exploded behind them. But the sequence was poorly planned and barely rehearsed, and the explosions damaged the rotor blades of the chopper, causing the pilot to lose control. As investigators examined the crash, they discovered that the children’s mere presence on the set had been illegal. A production secretary recalled Landis joking of the scheme, “We’re all going to jail!”

Persons: York Times’s Vincent Canby, John Landis, Vic Morrow, —, dismembering Morrow, Myca Dinh Le, Renee Shin, Yi Chen, Renee Shinn Chen, Landis, George Folsey Jr Organizations: Klan Locations: York, Nazi Germany, Vietnam

The indictments mark the first time the U.S. has sought to prosecute any of the Chinese companies responsible for manufacturing precursor chemicals used to make the painkiller. The companies at the heart of the three separate indictments are accused of selling precursor chemicals to the Sinaloa Cartel in Mexico, which in turn has flooded the U.S. with the drug. Federal prosecutors in Manhattan announced the unsealing of an indictment against the China-based chemical company Hubei Amarvel Biotech, along with its executives Qingzhou Wang, 35, Yiyi Chen, 31, and Fnu Lnu, also known as Er Yang, with fentanyl trafficking, precursor chemical importation, and money laundering offenses. "Fentanyl poses a singular threat, not only because the smallest doses can be lethal, but because fentanyl does not occur in nature. In the Eastern District of New York, prosecutors announced the unsealing of two more indictments against three other Chinese companies and individuals accused of conspiring to manufacture and distribute fentanyl in the U.S.

Persons: Antony Blinken, Joe Biden, Xi Jinping, Qingzhou Wang, Yiyi Chen, Fnu Lnu, Er Yang, Joaquin, El, Guzman, Lisa Monaco, Blinken, Wang, Chen, Yang, Sarah N, Lynch, Luc Cohen, David Brunnstrom, Chizu Nomiyama, Angus MacSwan Organizations: WASHINGTON, U.S . Justice, U.S, Hubei Amarvel Biotech, Justice Department, Embassy, Global Coalition, Administration, of, U.S . Prosecutors, Hebei Sinaloa Trading, Thomson Locations: United States, China, Washington, Sinaloa, Mexico, Manhattan, Hubei, cryptocurrency, Los Angeles, Honolulu , Hawaii, New York, of New York, Hebei Sinaloa, U.S

Search resuls for: "Yi Chen"

5 mentions found